Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Change in Accured Expenses came in at -$537000.0 in Q1 2026, down 161.87% year-on-year from $868000.0 in Q1 2025, and up 83.79% on a QoQ basis from -$3.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Change in Accured Expenses data on file, last reported at -$537000.0 in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 161.87% year-over-year to -$537000.0 in Q1 2026; TTM through Mar 2026 was -$2.5 million, a 163.48% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 129.24% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$537000.0, up from -$3.3 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for CWBHF reached as high as $5.0 million in Q4 2024 and fell as low as -$3.6 million in Q4 2022.
- Historically, Change in Accured Expenses has averaged -$83000.0 across 5 years, with a median of $33000.0 in 2025.
- Across the five-year window, Change in Accured Expenses tumbled 344.32% in 2022 and surged 280.47% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at -$3.6 million in 2022, then advanced by 22.7% to -$2.8 million in 2023, then jumped by 280.47% to $5.0 million in 2024, then tumbled by 166.37% to -$3.3 million in 2025, then surged by 83.79% to -$537000.0 in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$537000.0 in Q1 2026, -$3.3 million in Q4 2025, and $752000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -12.70 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | - |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -537,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -537,000.00 |
| Mar 31, 2026 | -537,000.00 |
| Dec 31, 2025 | -3.31 Mn |
| Dec 31, 2025 | -3.31 Mn |
| Sep 30, 2025 | 752,000.00 |
| Sep 30, 2025 | 752,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Jun 30, 2025 | 603,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 4.99 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | -980,000.00 |
| Sep 30, 2024 | -980,000.00 |
| Jun 30, 2024 | -949,000.00 |
| Jun 30, 2024 | -949,000.00 |
| Mar 31, 2024 | 663,000.00 |
| Mar 31, 2024 | 663,000.00 |
| Dec 31, 2023 | -2.77 Mn |
| Dec 31, 2023 | -2.77 Mn |